Canada’s reputation as a leader in cannabis relies on the consistent output of quality products. Our evaluation process encourages producers to continuously innovate and elevate their practices to cultivate the best dried flower in Canada and set a global standard for quality.

The CQA DNA Genotyping services allow producers to conduct preliminary phenotype and within a week of sprouting a seed as opposed to months of cultivation.

Genomic data is able to predict chemotypes (terpene, cannabinoid etc) profiles from seed or vegetative plants (conventional analytical chemistry requires mature and cured flower to generate chemotype data).

The CQA DNA Genotyping services effectively result in saving tremendous amount of time and energy to arrive at an optimal sky to go to market, validation and market support within the competitive segment.

CQA benefits from a cannabis DNA analysis database as well as having acquired a selected third party cannabis DNA Genotyping database. Every sample tested is added to the CQA database. This allows a proximity of samples to reference cultivars.

For a product submitted to CQA certification, our integration of sensory analysis, lab testing and genotyping furnishes useful information to producers.

For example, if the CQA Genotyping confirms that the genotype of the candidate is similar to other versions but the CQA sensory panel does not yield a favorable evaluation, this information allow to consult with the producer team on how to make improvements, based on the comments from the sensory panel. A contrario, with a favorable sensory but a dissimilar genotype, CQA offers to consult with the LP’s team on how to approach the market with this offering.